An older doctor sits in front of screens showing diagnostic imaging

五月 17, 2018

Philips invests $10 million in Cardeation Capital to combat heart disease

Estimated reading time: 1 minute

Share on social media

  • 鏈接已復制


New venture capital fund focuses on improving care for heart disease and stroke


Rates of cardiovascular disease are rising and costs are approaching $1 trillion annually in the United States. To ensure that effective innovations are rapidly introduced into the healthcare system, Philips, the American Heart Association and UPMC have partnered to create the $30 million Cardeation Capital venture capital fund.


The new fund will invest in emerging healthcare companies that can measurably affect the prevention and treatment of cardiovascular diseases and stroke — and their risk factors, such as diabetes. Cardeation Capital’s investors will fund best-in-class technology companies with scalable products and services that address healthcare delivery and health management.

Related insights

Want to become a start-up partner with Philips Ventures?

Changing healthcare

Together, we’re changing healthcare

Philips Ventures champions innovative start-ups with breakthrough solutions.

You are about to visit a Philips global content page


You are about to visit a Philips global content page


使用最新版 Microsoft Edge、Google Chrome 或 Firefox 瀏覽本網站效果最佳。